OpenAI, Thrive Capital Back AI Drug Discovery Startup – Marketscreener.com
From Google: 2024-09-09 16:10:58
OpenAI and Thrive Capital have invested in Notable, an AI drug discovery startup. Notable uses artificial intelligence to identify promising drug candidates, speeding up the drug development process. The company has raised $85 million in its latest funding round, bringing its total funding to $103 million. Notable aims to revolutionize the pharmaceutical industry with its innovative approach.
Read more at Google: OpenAI, Thrive Capital Back AI Drug Discovery Startup – Marketscreener.com